These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

580 related items for PubMed ID: 6429655

  • 1. Hyperthyroidism due to inappropriate TSH secretion with associated hyperprolactinaemia--a case report and review of the literature.
    Spitz IM, Sheinfeld M, Glasser B, Hirsch HJ.
    Postgrad Med J; 1984 May; 60(703):328-35. PubMed ID: 6429655
    [Abstract] [Full Text] [Related]

  • 2. Hyperthyroidism caused by a pituitary thyrotrophin-secreting tumour with excessive secretion of thyrotrophin-releasing hormone and subsequently followed by Graves' disease in a middle-aged woman.
    Kamoi K, Mitsuma T, Sato H, Yokoyama M, Washiyama K, Tanaka R, Arai O, Takasu N, Yamada T.
    Acta Endocrinol (Copenh); 1985 Nov; 110(3):373-82. PubMed ID: 3934894
    [Abstract] [Full Text] [Related]

  • 3. Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of "inappropriate secretion of TSH".
    Gershengorn MC, Weintraub BD.
    J Clin Invest; 1975 Sep; 56(3):633-42. PubMed ID: 1159077
    [Abstract] [Full Text] [Related]

  • 4. Familial hyperthyroidism due to inappropriate thyrotropin secretion successfully treated with triiodothyronine.
    Rösler A, Litvin Y, Hage C, Gross J, Cerasi E.
    J Clin Endocrinol Metab; 1982 Jan; 54(1):76-82. PubMed ID: 6798060
    [Abstract] [Full Text] [Related]

  • 5. Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: responses to thyrotropin-releasing hormone stimulation and short term triiodothyronine suppression.
    Sarne DH, Sobieszczyk S, Ain KB, Refetoff S.
    J Clin Endocrinol Metab; 1990 May; 70(5):1305-11. PubMed ID: 2110573
    [Abstract] [Full Text] [Related]

  • 6. Inappropriate thyrotrophin secretion, increased dopaminergic tone and preservation of the diurnal rhythm in serum TSH.
    Magee B, Sheridan B, Scanlon MF, Atkinson AB.
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):209-15. PubMed ID: 3085996
    [Abstract] [Full Text] [Related]

  • 7. Effects of thyroid hormones (T4,T3), bromocriptine and Triac on inappropriate TSH hypersecretion.
    Salmela PI, Wide L, Juustila H, Ruokonen A.
    Clin Endocrinol (Oxf); 1988 May; 28(5):497-507. PubMed ID: 3214942
    [Abstract] [Full Text] [Related]

  • 8. A case of the syndrome of inappropriate secretion of TSH.
    Sato T, Saida K, Suzuki Y, Takata I, Ishiguro K.
    Endocrinol Jpn; 1979 Oct; 26(5):623-30. PubMed ID: 230960
    [Abstract] [Full Text] [Related]

  • 9. Effect of dexamethasone on prolactin and TSH responses to TRH and metoclopramide in man.
    Sowers JR, Carlson HE, Brautbar N, Hershman JM.
    J Clin Endocrinol Metab; 1977 Feb; 44(2):237-41. PubMed ID: 402375
    [Abstract] [Full Text] [Related]

  • 10. Dissociation of responsiveness to thyrotropin-releasing hormone and thyroid suppressibility following antithyroid drug therapy of hyperthyroidism.
    Martino E, Pinchera A, Capiferri R, Macchia E, Sardano G, Bartalena L, Mazzanti F, Baschieri L.
    J Clin Endocrinol Metab; 1976 Sep; 43(3):543-9. PubMed ID: 821960
    [Abstract] [Full Text] [Related]

  • 11. Bromocriptine therapy for hyperthyroidism due to increased thyrotropin secretion.
    Takamatsu J, Mozai T, Kuma K.
    J Clin Endocrinol Metab; 1984 May; 58(5):934-6. PubMed ID: 6707194
    [Abstract] [Full Text] [Related]

  • 12. Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis.
    Kaplan MM, Taft JA, Reichlin S, Munsat TL.
    J Clin Endocrinol Metab; 1986 Oct; 63(4):808-14. PubMed ID: 3091628
    [Abstract] [Full Text] [Related]

  • 13. A case of inappropriate non-neoplastic secretion of TSH treated with bromocriptine.
    Yeğen C, Aktan AO, Saraç AM, Yalin R.
    Endocr Regul; 1993 Mar; 27(1):23-5. PubMed ID: 8003703
    [Abstract] [Full Text] [Related]

  • 14. Syndrome of 'inappropriate secretion of thyroid-stimulating hormone' by partial target organ resistance to thyroid hormones.
    Salmerón De Diego J, Rodriguez CA, Orlando AS, Cervigon PS, Mutazzi EC, Mateos JM.
    Acta Endocrinol (Copenh); 1981 Jul; 97(3):361-8. PubMed ID: 6789594
    [Abstract] [Full Text] [Related]

  • 15. A human pituitary adenoma secreting thyrotropin and prolactin: immunohistochemical, biochemical, and cell culture studies.
    Jaquet P, Hassoun J, Delori P, Gunz G, Grisoli F, Weintraub BD.
    J Clin Endocrinol Metab; 1984 Nov; 59(5):817-24. PubMed ID: 6480809
    [Abstract] [Full Text] [Related]

  • 16. Effect of prolonged oral administration of TRH on plasma levels of thyrotrophin and prolactin in normal individuals and in patients with primary hypothyroidism.
    Frey HM, Haug E.
    Acta Endocrinol (Copenh); 1977 Aug; 85(4):744-52. PubMed ID: 407759
    [Abstract] [Full Text] [Related]

  • 17. The interrelationships between prolactin and thyrotrophin secretion following dopaminergic blockage in patients with mild hyperprolactinaemia without any demonstrable pituitary tumour.
    Spitz IM, Haas M, Trestian S, Zylber-Haran E, Shilo S.
    Clin Endocrinol (Oxf); 1983 Sep; 19(3):285-94. PubMed ID: 6414745
    [Abstract] [Full Text] [Related]

  • 18. [Resistance to thyroid hormone and Hashimoto's thyroiditis].
    Guerra-Argüero LM, Gutiérrez-Saucedo JA, Gómez-Coello A, Gállego-Suárez C, Vázquez Mellado-Septién A.
    Cir Cir; 2011 Sep; 79(5):453-7. PubMed ID: 22385766
    [Abstract] [Full Text] [Related]

  • 19. [Hyperthyroidism and subjects hyperresponding to thyrotropin. Importance of simultaneous thyrotropin and prolactin determination following administration of thyroid-releasing hormone].
    Schlienger JL, De Laharpe F, Reville P, Stephan F.
    Sem Hop; 2011 Sep; 56(17-18):827-31. PubMed ID: 6248964
    [Abstract] [Full Text] [Related]

  • 20. Plasma thyrotropin-releasing hormone, prolactin, thyrotropin, and thyroxine concentrations following the intravenous or oral administration of thyrotropin-releasing hormone.
    Andreassen B, Huth J, Tyson JE.
    Am J Obstet Gynecol; 1979 Nov 15; 135(6):737-42. PubMed ID: 115316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.